glp-1 gallbladder Why are agonists being used to treat patients with nonalcoholic fatty liver disease? no gallbladder and glp 1
Description
In the U.S., GLP-1 prescriptions more than doubled in just 18 months, topping nine million by early 2024
Accurate well-documented CNS and GI effects
While not entirely preventable, you can minimize fatigue by ensuring adequate caloric and protein intake despite reduced appetite, staying well-hydrated, following a gradual dose escalation schedule, and maintaining regular moderate physical activity
High-risk medications include anticonvulsants, sulfonamide antibiotics, allopurinol, NSAIDs, nevirapine, and abacavir
